Literature DB >> 32497217

Effects of Proximal and Distal Enteral Glucose Infusion on Cardiovascular Response in Health and Type 2 Diabetes.

Xiang Zhang1,2, Karen L Jones1, Michael Horowitz1, Christopher K Rayner1, Tongzhi Wu1,3.   

Abstract

CONTEXT: Exposure of the small intestine to nutrients frequently leads to marked reductions in blood pressure (BP) in type 2 diabetes (T2DM). It remains unclear whether the region of the gut exposed to nutrients influences postprandial cardiovascular responses.
OBJECTIVE: To evaluate the cardiovascular responses to proximal and distal small intestinal glucose infusion in health and T2DM.
DESIGN: Double-blind, randomized, crossover design.
SETTING: Single center in Australia. PATIENTS: 10 healthy subjects and 10 T2DM patients.
INTERVENTIONS: Volunteers were studied on 2 occasions, when a transnasal catheter was positioned with infusion ports opening 13 cm and 190 cm beyond the pylorus. A 30-g bolus of glucose was infused into either site and 0.9% saline into the alternate site over 60 minutes. MAIN OUTCOME MEASURES: BP, heart rate (HR), and superior mesenteric artery (SMA) blood flow were measured over 180 minutes.
RESULTS: Systolic BP was unchanged in response to both infusions in health, but decreased in T2DM, with a greater reduction after proximal versus distal infusion (all P ≤ .01). The increment in HR did not differ between treatments in health, but was greater after distal versus proximal infusion in T2DM (P = .02). The increases in SMA blood flow were initially greater, but less sustained, with proximal versus distal infusion in health (P < .001), a pattern less evident in T2DM.
CONCLUSIONS: In T2DM, postprandial hypotension may be mitigated by diversion of nutrients from the proximal to the distal small intestine. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cardiovascular function; diabetes; enteral infusion; type 2

Mesh:

Substances:

Year:  2020        PMID: 32497217     DOI: 10.1210/clinem/dgaa341

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  1 in total

Review 1.  Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin.

Authors:  Malcolm J Borg; Christopher K Rayner; Karen L Jones; Michael Horowitz; Cong Xie; Tongzhi Wu
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.